SCHEMBL8851559

SCHEMBL8851559

CCCN(CCC)C(=O)CCN(C)C1CC[N]CC1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
HPGD P15428 1/20 0.42
LMNA P02545 1/20 0.32
CA12 O43570 1/20 0.32
CA2 P00918 1/20 0.32
CA9 Q16790 1/20 0.32
ADH1A P07327 2/20 0.31
ADH1C P00326 1/20 0.31
SIGMAR1 Q99720 1/20 0.31
POLB P06746 1/20 0.30
APEX1 P27695 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
PKM P14618 1/20 0.30
SMYD3 Q9H7B4 1/20 0.30
TSHR P16473 1/20 0.30
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9229788 0.91 ALDH1A1 (0.40) ALDH1A1HPGDLMNACA12CA2
SCHEMBL8851326 0.89 LMNA (0.46) LMNA
SCHEMBL8850969 0.86 ALDH1A1 (0.36) ALDH1A1HPGDLMNACA12CA2
SCHEMBL8851228 0.84 ALDH1A1 (0.42) ALDH1A1HPGDCA12CA2CA9
SCHEMBL8851299 0.83 ALDH1A1 (0.35) ALDH1A1
SCHEMBL9235544 0.83 ALDH1A1 (0.41) ALDH1A1HPGDLMNACA12CA2
SCHEMBL8851562 0.81 SIGMAR1 (0.42) ALDH1A1HPGDLMNASIGMAR1
SCHEMBL9282409 0.80 LMNA (0.47) ALDH1A1HPGDLMNATSHR
SCHEMBL8117729 0.79 DRD2 (0.36) ADH1AADH1CSIGMAR1
SCHEMBL8851282 0.79 ALDH1A1 (0.40) ALDH1A1HPGDLMNASIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5618814-A Trisubstituted pyrimido [5,4-d] pyrimidines for modulating multi-drug resistance and pharmaceutical compositions containing these compounds DR. KARL THOMAE GMBH (DE) 1997-04-08 US disclosed
EP-0645390-A1 Trisubstituted pyrimido 5,4-d pyrimidines for modulating multidrug resistance, drugs containing these compounds and processes for their preparation Dr. Karl Thomae GmbH (DE) 1995-03-29 EP disclosed